Sort
64,565 grants matching “drug discovery”
Temporal, Spatial and Cellular Dynamics of Amyloid Plaque Deposition
$734,137Charles G Glabe · University Of California-Irvine · R01 · FY2025 · AG
Discovery and validation of drug resistance mutations
$734,112Eric H. Rubin · Harvard Medical School · U19 · FY2017 · AI
MPS Resources Section
$733,997James L McGrath · University Of Rochester · U2C · FY2025 · AG
Advancing drug repositioning and development for Alzheimer's Disease using functional genomics and computational phenomics
$733,967Eric R Gamazon · Vanderbilt University Medical Center · R56 · FY2022 · AG
New drugs for non-tuberculous mycobacterial (NTM) lung disease in patients with cystic fibrosis
$733,919Thomas Dick · Hackensack University Medical Center · U19 · FY2019 · AI
Selective inhibitors of MLCL/CytC Peroxidase in Barth Syndrome
$733,848Valerian E Kagan · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HL
Bloomington Drosophila Stock Center at Indiana University
$733,806Kevin R Cook · Trustees Of Indiana University · P40 · FY2019 · OD
Molecular, Cellular, and Tissue Characterization Unit
$733,794Joe W. Gray · Oregon Health & Science University · U2C · FY2020 · CA
Early Stress and the Neurobiology of Susceptibility and Resilience to Substance Use Disorders
$733,785Martin H Teicher · Mclean Hospital · R01 · FY2024 · DA
Epigenetic Marks of Cocaine Addiction
$733,621Deborah C. Mash · University Of Miami School Of Medicine · R01 · FY2014 · DA
Genomic Background of Blood Pressure Response to Thiazide Diuretic in African Americans
$733,590Marguerite R Irvin · University Of Alabama At Birmingham · R01 · FY2017 · HL
Rational design of bifunctional protein degrader drugs
$733,586Karteek Kadimisetty · Lifesensors, Inc. · R44 · FY2022 · GM
SBIR Phase II: Cheminformatics Teaching Tools for the Cheminformatics Virtual Classroom
$733,583Norah E Maccuish · Mesa Analytics & Computing, Llc · · FY2005 · TIP
Organic photoredox catalysts as sustainable and cost-effective replacement forprecious metal complexes in light-driven drug synthesis
$733,549Chern-Hooi Lim · New Iridium · R44 · FY2021 · GM
Cannabinergic Medications for Methamphetamine Addiction
$733,538Alexandros Makriyannis · Northeastern University · R37 · FY2014 · DA
Host Genetics of HIV-1 Subtype C Infection, Progression, and Treatment in Africa
$733,469Myron E Essex · Harvard School Of Public Health · R01 · FY2008 · AI
Lead optimization of novel CRFBP-CRFR2 complex modulators for alcohol use disorder
$733,411Douglas J Sheffler · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · AA
Examining Carbon Monoxide to Treat Inflammatory Conditions using Experimental Colitis Models
$733,350Binghe Wang · Georgia State University · R01 · FY2019 · DK
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY
$733,329Harvard University (Medical School) · U19 · FY2000 · CA
Structural Determinants of PIP2 Regulation
$733,308Diomedes E Logothetis · Northeastern University · R01 · FY2024 · HL
Variation in platelet function: the genetics of platelet gene expression
$733,228Paul F. Bray · Thomas Jefferson University · R01 · FY2011 · HL
Modeling hyperactivity in neurological disease using patient-derived pluripotent stem cells
$733,227Fred H Gage · University Of Pennsylvania · U19 · FY2020 · MH
Highly Specific ZFN-Based HSC Gene Editing Therapies Identified By In Vivo Barcode Nanoparticle Screens And Rationally Designed Mrna
$733,169James Dahlman · Georgia Institute Of Technology · UG3 · FY2021 · TR
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease
$733,145Mark W Albers · Massachusetts General Hospital · R01 · FY2022 · AG
Neurobehavioral Relations in Senescent Hippocampus
$733,036Carol A. Barnes · University Of Arizona · R01 · FY2020 · AG